Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 12Breast 11Thoracic 7Head & Neck 3Genitourinary 3CNS 3Gynecologic 2Dermatologic 2Sarcoma 1Lymphoid 1

Conditions

Melanoma 2Skin Neoplasms 1Nevus 1Dysplastic Nevus Syndrome 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 195aldesleukin 148Interleukin-2 110fludarabine phosphate 107trametinib 85Temozolomide 83fludarabine 81Dacarbazine 81dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Magnetic Resonance Spectroscopy 50Specimen Handling 49Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Aminolevulinic Acid 49binimetinib 48Carboplatin 48Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diagnostic Imaging × Dermatologic × Clear all
NCT05446155 2024-01-23

BioMEL

Region Skane

Recruiting
2,000 enrolled
Dermatologic

Dysplastic Nevus Syndrome, Melanoma, Nevus, Skin Neoplasms

NCT04253574 2020-02-05

Comparison of PET/CT and Ultrasound in Staging of Malignant Melanoma

University of Basel

Completed
258 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡